Two Biotech Stocks on Takeover List?

Why These 2 Biotech Stocks Might Be Next On The Takeover List (IBD). Acadia Pharmaceuticals (ACAD) and Neurocrine Biosciences (NBIX) stand...
revelers.io

Low Carbs and AFIB?

Low-Carb Diets Could Increase Risk of Heart Rhythm (UK Independent). Popular low-carb diets promoted by celebrities including Gwyneth Paltrow and...
video

Dyadic (DYAI) Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ

JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange...
biotech stock review

Adding Mustang Bio (MBIO) $4.00 to Watchlist After Investor Presentation.

We met with management at Company-sponsored lunch at Ruth Chris in Boca Raton last week and we came away extremely enthusiastic about...
Dr. Lindsay Rosenwald

Dr Lindsay Rosenwald, Biography.

Wall Street Transcript Interview (2018) IDB Bank Profile Biography (2011) LR Facts*, below. For...
biotech stock review

Orchestra BioMed™ Announces Completion of $41 Million Financing.

November 15, 2018 Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and...

Immunomedics Chairman Buys $19 Million More in Stock.

(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132,...
Steven Boyd, Armistice

Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).

A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied...

Latest article

Asia-Pacific: A Region of Stability Amidst Economic Uncertainty

Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in...

Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...

Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...

A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...